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Purified porcine rythrocyte membrane Ca:*-ATPase and 3':5'-cyclic nucleotide phosphodiesterase were stimulated ina dose-dependent, saturable 
manner with the vitamin D-dependent calcium binding protein from rat kidney, calbindin-D~k (CaBP-D2~). "fhe concentration f CaBP-D~ 
required for half-maximal ctivation (K~,~ act,) of the Ca:*-ATPase was 28 nM compared to 2.2 nM for calmodulin (CAM), with maximal activation 
equivalent upon addition of either excess CaM or CaBP-D2~. 3':5'-Cyclic nucleotide phosphodiesterase (PDE) also showed equivalent maximum 
saturable activation by calbindin (K,j.5 act, = 90 nM) or ¢almodulin (/~.~ act. = 1.2 nM), CaBP-D.~ was shown to effectively compete with 
CaM-Sepharose for PDE binding, Immannprecipitation with CaBP-D.x~ antiserum completely inhibited calbindin.mediated activation of PDE but 
had no effect on calmodulin's ability to activate PDE, While the physiological significance of these results remains to be established, they do suggest 
that CaBP-D.,K~ can activate nzymes and may be a regulator of yet to be identified target enzymes in certain tissmm. 
Calbindin; Ca-"-ATPas¢; Phosphodiesterase; Calmodulin; Enzyme activation 
1. INTRODUCTION 
Calcium plays a central role in mediating a variety of 
biological processes, for instance secretion, contraction, 
maintenance of bones and teeth, cell division, growth 
and the functioning of various receptors and enzymes. 
An important link in the molecular mechanism by 
which calcium mediates these processes is a class of 
calcium binding proteins with dissociation constants for 
Ca 2÷ in the micromolar range that are postulated to be 
major targets of biological signals [1,2]. Members of this 
class of calcium binding proteins include calmodulin, 
troponin C, SI00 protein, parvaibumin and the vitamin 
D-dependent calcium binding proteins, the 9 and 28 
kDa calbindins. Calbindin-D,~k (CaBP-D00 is present in 
mammalian intestine and CaBP-D_,sk, a phylogeneti- 
tally conserved protein, is found in avian intestine and 
in reptilian, avian and mammalian kidney and brain as 
well as in squid brain [3,4]. Although much is known 
biochemically and functionally concerning other 
members of the family of calcium binding proteins, the 
exact physiological significance of the ¢albindins is still 
unknown. Studies indicate that both CaBP-Dgk and 
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CaBP-D2sk can serve as facilitators of diffusion and 
intracellular buffers for calcium [5-7]. What remains to 
be determined is whether the vitamin D-dependent 
calcium binding proteins modulate specific enzyme ac- 
tivities similar to (calmodulin) CaM or function simply 
as intracellular calcium buffers. Several reports uggest 
that calcium may mediate onformational changes in 
the calbindin molecule which facilitate the interaction 
of caibindin with other cellular constituents [8,9]. 
Recently, studies by Waiters have indicated that CaBP- 
D,~k can stimulate intestinal basolaterai membrane 
calcium pumping activity [10,11]. In addition, James et 
al. identified the primary structure ofa  CaBP-D,~k bind- 
ing domain in the plasma membrane Ca 2+ pump [12]. 
In earlier studies, we reported that rat CaBP-D~k speci- 
fically stimulates Ca2+Mg2÷-ATPase activity in human 
erythrocyte plasma membrane preparations in a dose- 
dependent manner [13]. The work described here tested 
whether at CaBP-D2~k could stimulate and bind to 
purified Ca2+-ATPase and whether 3':5'..cyclic nu- 
cleotide PDE, another CaM-regulated enzyme, could 
also be activated by the 28 kDa ealbindin. 
2. MATERIALS AND METHODS 
2.1. Materials 
Calmodulin was isolated from bovine t~tes [14] and subsequently 
linked to Sepharose 4B [I 5]. CaBP-D:,~ was isolated from rat kidney 
utilizing a final step of preparative gel electrophoresis followed by 
storage at -20"C in 0.01 M Tris-HCl [16J. Activator-deficient 3':5" 
cyclic nucleotide phosphodiestems¢ (PDE) from bovine brain was 
purchased from Sigma and r~onstituted in a 50% glycerol solution 
for all assays. Rabbit anti-CaBP-Duk antiserum was raised against rat 
kidney CaBP-D~k and shown to be specific for CaBP-Dm as previ. 
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oualy described [l6]. Human cryUlrocylc membrane Ca”-ATPasc 
I’rom otndaicd bank blood or porcine erythrocylc mcmbranc Ca”- 
AT&e rrom l&h porcine blood was purilicd by C;IM-Scpharosc 
alIinily column chromaloyriiphy [ 171, 
Phosphodieslcrnse I. (5’~nucleolidusc) and Protein A-Sephnrosc 
were obtained IYom Sigma as were all olhcr chemicals used unless 
olhcrwisc noted. 
2 .?. , Cu?*-/I Thw rrcririr I’ NSSU,L’S 
Delcrgenl solubilizcd ‘Ca”-ATPase was assayed as originally de- 
scribed [I71 in a 1100 ~1 reaction mixture containing I yg or Cd“- 
ATPasc. Reactions were carried out a1 37OC I’or IO min in the prcscncc 
or CaM conccmralions ranging l’rom O-,30 nM, or GDP-D2,, con- 
ccntralions rnnging lion1 O-250 nM. ATP hydrolysis was measured 
colorimclricully by the detection or rcleascd inorganic phosphate [ 181. 
Ca2+-ATPasc stimulation was calcul;\ted by subtracting basal ATPase 
activily in the abscncc 01’ CaM or CaBP-Dzhl from maximal aclivhy 
obtained in ~hc prescncc orexcess CaM. This diKercnce WBS given lhe 
dcsignalion of 100% slimulation. Approprinlc controls were includL4 
to discounl the possibility orbackground phosphalcconlamination or 
any clTcct Ihat CaM or CuBP-D:,, preparations had on ATP hy- 
drolysis in the abscncr ol’ added Cd”-ATPase. Each poinl is lhe 
uverugc ol’Z independent determinations (+S.D.). 
2.3. 3’:s’.C,rcfic trttrlcofidc plto.s(,ltitrlicsrc~~ft.s~ ricriviry ~ts~qw 
Cyclic nuclcotidc PDE aclivity was measured using a Iwo-stage 
assay proccdurc described by Wallace cl al. [I91 in a 200 ~1 reaction 
mixture containing 2 x IO-> U PDE; however. released inorganic 
phosphate was measured colorimctricnlly [l8]. PDE stimulation was 
achicvcd by inclusion 01’ CaM conc~nlralions ranging from O-30 nM 
and &BP-D,,, conccn1ralions ranging l’rom O-250 nM. Additional 
PDE assays were pcrl’ormed in the presence of I50 nh4 CaM or 
CuBP-DzNa (Fig. IB) cithcr in a rcaclion mixture conlaining 0,I mM 
CaCIz or with Ihe addilion 01’ EGTA lo a final concenlralion 01’ 10 
mM. PDE stimulation was calculalrd by subtracting basal activity in 
the absence of CaM I’rom maximal activity in the presence of excess 
CaM and designaling lhis as 100% stimulation, Appropriate controls 
were included to discount the possibiliiy or background phosphate 
conttimination or any cKec1 of CeM or CdBP-DIsI on CAMP hy- 
drolysis in [hc absrncc ol’ PDE. Each poim rcpresenls the average 01 
3 indcpcndcnt determinations (2S.D.). 
2.4. Itttttitrttr~~~r~~ci(,irrrriutt i~~‘~tltos~~it~~li~.srcrwse .stittt~r/frlitfg ocli~~iiy 
20 ng of CaM or 500 ng or CaBP-Dl,t in 20 ~1 Tris-bull’cred saline 
wcrc exposed LO 5 ~1 or rabbit ami-CaBP-D2,, antiserum or 5 91 or 
preimmunc rabbit serum for I h a14”C. AlIcrwards. 10~1 ol’a Prolein 
A-Scpharose slurry wds added and the mixlure allowed 10 incubate 
wilh gentle agitationat 4OC for I h. Followingcenlril’ugation at 10.000 
x g for 30 s. 25 pl ol’ supcrnatam was removed and assayed for iu 
ability LO aclivatc PDE as described above. Stimulation values were 
corrected Ibr dilution of aclivator during the immunoprecipi~alion. 
Values obtained from blanks comaining only serum and Protein A- 
Sepharose were sub\ractcd to obtain the indicated slimulalion values. 
PcrcentageoTmaximum slimulalion is represented asdcscribed for the 
normal PDE assay above. 
A 200,~l PDE reaction mix in 50 mM Tris, pH 8.0, 25 mM am- 
monium acc~ale, 5 mM dithiothrehol, 0.10 mM C&I, and 3 mM 
MgCI, containing 2 x 10eJ U of PDE aclivity was aliquottcd into 
IS-mi mirrofugc tubes. The minimum amount or a CaM-Sepharose 
slurry required to completely remove all PDE activity batchwise Tram 
the reaction mixture was determined by titration 10 be 20 ~1 I’rom a 
representative CaM-Scpharose preparation. Increasing quantities or 
CaM (O-l ~6) or GDP-D?,, (O-B//g) diluted in 20@ orrcaclion bur’rer 
wcrc added to the ?O jrl oT CaM-Sepharose slurry. This mixiurc was 
then added LO individual 200 ~1 PDE reaction mixes allowing si- 
multaneous cxposurc oT the PDE to CaM-Sepharose and Tree CaM 
or CaBP-D2,h. Fig. 4 represents lhe final concentration of CaM or 
CaBP-D?,, akcr addition to the PDE reaction mix. The mixture was 
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incubated for IO min at room lempcrature I’ollowed by ccniriruguiion 
at 10.000 x g for I min to remove CnM-Scpharose-bound PDE. The 
supernalant was irunsrerrcd io a fresh tube and CAMP and CdM were 
added LO 0.25 mM and 150 nM. rcspcctivcly. rollowed by incubalion 
a1 37°C Tar IO min to dclcrminc PDE activity rcmnining in the ruper- 
nutants. The excess CaM woo included in assays LO insure maximal 
acliviilion or all remaining PDE in the supcrnauux. Activily was 
measured as dcscribcd above. No CaM-Sepharosc added corresponds 
10 100% aclivhy :xnaining in supernntuni and 20 ~1 CaM Sepharose 
added corresponds lo 0% activily remaining in supcrnaiant. A convol 
uxperimcnt involved substitution Tar CaBP-D.,, in the pra-incubation 
with cilhcr 2 pug concanuvalin A or 2 lug bov& serum albumin. No 
PDE aciivily was dclecicd in the supcrnatants 01’ thcsc conlrols. 
Calmodulin concentration I-or USC in all assays was dclcrmined by 
amino acid analysis [20]. CaBP-D zIIk conccnlraLion for aSsayS was 
dclermincd by the me\hod of Lowry [Zl] or using the BCA assay 
prolocol (Pierce). SDS-PAGE was cxricd out according LO Lacmmli 
[2?]. Silver sluining of SDS-polyacrylsmidc gels was carried oul as 
described by Morrisscy [Xl. 
3. RESULTS 
The effect of CaBP-D,,, on activator-deficient PDE 
activity was measured and compared to the known sti- 
mulatory effect of CaM on PDE as shown in Fig. I [24]. 
In both instances, maximum PDE stimulation above 
basal activity was achieved and the stimulatory activity 
based on activator concentrations was saturable. Al- 
though maximum stimulation by CaM and CaBP-D,,, 
was comparable, there was a significant shift of the 
dose-response curves. The concentration for half-maxi- 
mal stimulation by CaM was 1.2 nM and by CaBP-DINk 
was 90 nM. Maximal stimulation was achieved at a 
CaM concentration between 8 and 10 nM but only at 
CaBP-Dl,k concentrations above 200 nM, From the 
results in Fig. IA it was not clear if the activation of 
PDE by CaBP-DzNk was a Ca”+-dependent pheno- 
menon. To address this question, PDE activation assays 
were performed (Fig, 1 B) in the presence of either CaCI, 
alone, or CaCI, plus excess EGTA. All other conditions 
were exactly as used for Fig. IA. The sequestration of
Ca’+ by EGTA effectively abolished the ability of CaM 
to activate PDE but had no effect on the stimulatory 
activity of CaBP-D2,,. Controls for the experiments re- 
presented in Fig. 1A and B confirmed that CaBP-Dzsk 
had no effect on the hydrolysis of CAMP in the absence 
of PDE (data not shown). Similar results were obtained 
whether CAMP hydrolysis was measured by phosphate 
release as described in Materials and Methods or using 
the [“HIcAMP assay of Wallace [19]. 
3.2. Actiwtion of purljkl erytlwocyte membrwc Cu’+- 
A TPme with rclt kidtwy CUBP-D~~~ 
An additional C&i-sensitive enzyme, erytinrocyie 
membrane Ca?+-ATPase was also activated in a dose- 
dependent manner by C ..:BP-Dlnk as shown in Fig. 2. 
Detergent-solubilized porcine erythrocyte membrane 
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Fig. 1. Effect oI'CaBP-D_,~ and CaM on bovine Y:5'-¢yclic nucleotide 
phosphodiesteras¢ ctivity. (A) Representation F PDE activity assays 
performed in the presence of increasing concentrations of CaM (o) or 
CaBP-D.,~k (O). (B) The effect of EGTA on CaM and CaBP-D:~ 
stimulation of PDE activity. Assays were performed and results arc 
expressed as described in Materials and Methods, 
Ca2+-ATPase activity was monitored as described in 
Materials and Methods in the presence of CaBP-D.,sk or 
CaM. In both cases, Ca"~-ATPase activity was fully 
stimulated in a saturable manner. The concentrations of 
CaM or CaBP-D:,~ required for half-maximal ctiva- 
tion were 2.2 nM and 28 nM, respectively. Full stimula- 
tion of Ca"÷-ATPase was observed at a CaM concentra- 
tion of 15-20 nM and a CaBP-D,~ concentration of
150-200 riM. Subsequent studies showed that human 
erythrocyte Ca2+-ATPase isolated from outdated bank 
blood, as described by Niggli et al. [17] and assayed as 
described in Materials and Methods, was also stimu- 
lated by nM concentrations of CaBP-D.,~ (data not 
shown). In the absence of' Ca'-+-ATPase, no ATP hy- 
drolysis was observed with CaBP-D~k. 
3.3. Et,idence for the mechanism of CaBP-D,~k activa- 
tion of PDE and Ca:+-A TPase 
CaM-Sepharos¢ batch adsorption (Fig. 3) was used 
to assess the ability of CaBP-D:~k to effectively compete 
with CaM for binding to PDE. Fig. 3 demonstrates that 
the CaM concentration required to effectively release 
50% of PDE activity from CaM-Sepharose binding was 
3 nM (Fig. 3, open circles), as compared to 600 nM for 
Q_ 
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Fig. 2. Effect oFCaBP-Da~k and CaM on purified porcine rythroeyte 
membrane Ca"'-ATPase activity. Activity assays on detergent.solubil. 
ized porcine Ca'-+-ATPase purified and assayed as described in Ma- 
terials and Methods were performed in the presence of increasing 
concentrations oi" either CaM ((3) or CaBP-D.,hk (0). 
CaBP-D2,k (Fig. 3, closed circles). These numbers are 
not strictly quantitative due to the nature of batch 
adsorption. However, they do serve to illustrate that 
CaBP-D,~k interacts with PDE in a manner competitive 
with CaM, but with much lower affinity. Bovine serum 
albumin or concanavalin A had no effect on the interac- 
tion of PDE with CaM-Sepharose (data not shown). 
The results suggest hat CaBP-D~sk activates PDE by 
binding to the enzyme at or near the CaM binding 
domain in a manner analogous to CaM. Additionally, 
calcium-independent bi ding of U~l-labelled CaBP-D_,,k 
to nitrocellulose-bound human erythrocyte Ca'-~-ATP- 
ase has been demonstrated ( ata not shown), 
Several experiments were performed in order to de- 
monstrate that PDE or Ca"+-ATPase were not being 
activated by limited proteolysis in the presence of 
CaBP-D:,~. There were necessary since it has been pre- 
viously shown that limited proteolysis activates these 
enzymes by making them independent of CaM [23,24]. 
c-100 o~o CaM o 
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~._= o 
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Fig. 3. Inhibition or Y'.5"-cyclie nueleotide phosphodiesterase binding 
to CaM-Sepharose with free CaBP-D:~ or CaM. Increasina amounts 
of CaBP-Da~ (O) or CaM (O) were used [o inhibit he interaction 
between CaM-Sepharose and PDE. Following centrifugation, super- 
natanis were assayed for PDE activity as described in Materials and 
Methods. 
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PDE was incubated with 150 nM CaBP-D,,, in an assay 
reaction buffer (see Materials and Methods) for 10 min 
at 37°C t’ollowed by the llddition of excess CaM-Sepha- 
rose. After centrifugation. all PDE activity was effecti- 
vely removed from the supernatant indicating that the 
ability of PDE to interact with CaM-Sepharose was 
unimpaired by pre-exposure to CaBP-DzXk. Thus, 
CLIBP-D~,~ does not irreversibly alter the CaM binding 
domain (data not shown). Additionally, PDE and human 
erythrocyte Ca”‘-ATPase were pre-incubated individually 
with 150 nM CitBP-D~~k followed by SDS-PAGE and 
silver stain analysis. A control ane containing no CaBP- 
Dznk was inchtdcd for comparison. No proteolytic 
breakdown of PDE was observed (data not shown). 
3.4. Tile obser~d mm’votiort effects of CnBP-D, crrtd 
CUM NW proteh-.vpeciJic twl itzriqmht of otw 
arrotlwr 
A variety of treatments have been shown to activate 
the Ca?+-ATPase and PDE [2,26]. not all of which are 
protein-mediated. Two experiments were performed to 
show that &BP-D,,, specifically activates PDE and is 
virtually free from CaM contamination. As shown in 
Fig. 4. immunoprccipitation with anti-CaBP-D,,, (solid 
bars) or preimmune (hatched bars) sera had no effect on 
cahnodulin’s ability to activate PDE. However, immu- 
noprecipitation with anti-CaBP-Dzyh antisera (solid 
bars) completely inhibited CaBP-Dzxk mediated activa- 
tion of PDE. Preimmune serum had no effect on activa- 
tion by CaBP-D2Xk (open bars). This indicates that the 
effect of CaBP-Dztik on PDE is specific for CaBP-D,,, 
Q hcttvator only 
Calmodulin Calbindin-D28K 
Fig. 4. lmmunoprecipitation f PDE-stimulating activity from a 
purified CUBP-D~,~ prcparntion using CaBP-D2,,+pecific antiserum. 
CaM (20 ng) or &BP-Dak (500 ng) were immunoprL%ipitated with 
either no antisera (hatched bars), preimmunc antiserum (solid bars) 
or CaBP-D:,,-specilic antiserum (open bars) and supcrnatnnts were 
m%iyCd for their ability to stimulate PDE activity as described in 
Materials and Methods. Each bar signifies a single representalive 
determination. 
and is not the result of contamination with CaM or 
other undefined activating factors. SDS-PAGE with 
silver stain analysis of purifted CaBP-D,+ also failed to 
detect any contaminating polypeptides including CaM 
(data not shown). Parvalbumin and troponin C, at con- 
centrations greater than those required for activation by 
CaBP-Dznk, did not activate PDE or Ca’+-ATPase (data 
not shown). 
4. DISCUSSION 
The CL?+-pumping ATPase is a polypeptide of M, 
of approximately 138,000 which is present in all mam- 
malian cell plasma membranes [36]. The stimulation of 
CL?+-ATPase by CaM, which results in an increase in 
the affinity of the enzyme for calcium as well as an 
increase in the enzyme’s maximal transport rate, has 
been well documented [27,2S]. The distribution of cal- 
bindin along the villus-crypt axis in the intestine and in 
the distal tubule of the kidney correlates with the lo- 
calization of epitopes of the plasma membrane calcium 
pump in these tissues [29,30], suggesting that the plasma 
membrane calcium pump and calbindin may be part of 
the same calcium transporting system, and that cal- 
bindin, similar to CaM, may also stimulate the Ca’+- 
ATPase. However, previous reports have described 
either no effect or a stimulatory effect of the vitamin 
D-dependent calcium binding proteins, CaBP-D,, and 
CLIBP-D-,,~, on Ca2+Mg”+-ATPase activity [ 13.3 l-351. 
Similarly, inconsistent effects of vitamin D administra- 
tion to vitamin D-deficient animals on intestinal Cal+- 
ATPase activity have been reported. Recently, James et 
al. [12] presented evidence that CaBP-D,], interacts with 
the CaM binding domain of purified human erythrocyte 
Ca”’ pump in a calcium-dependent manner, although at 
a much lower affinity. However, activation of the 
purified Ca”‘-ATpasc was not demonstrated. Our study 
indicates that CaBP-Dzyk does activate purified porcine 
or human erythrocyte membrane Ca”-ATPase in a 
manner similar to CaM although with a IO-fold lower 
affinity. Similarly, activation of 3’:5’-cyclic nucleotide 
PDE with CaBP-Dask was also demonstrated, but re- 
quired 100-fold more CaBP-DIBk than CaM for equiv- 
alent activation. In addition, C~IBP-D~~~ effectively 
released PDE activity from CaM-Sepharose, suggesting 
that CaBP-DzBk does interact with PDE in a manner 
competitive with CaM but at a lower affinity under 
these conditions. Unlike James et al. [12] we did not 
observe calcium-dependent binding of CaBP-Dltik to the 
ATPase. Activation of PDE also was not CL?+-depend- 
ent. Similarly, using the gel overlay technique of 
Glenney et al. [3G], binding of ‘2J1-labelled CaBP-DzBk 
to soluble rat brain and kidney proteins was con- 
sistently found to be calcium-independent (S. 
Christakos, unpublished results). In addition, Bikle et 
al. [37] using the same gel overlay technique, found that 
binding of rat kidney and chick gut calbindins to a 
130 
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105kDa CaM binding protein, found in intestinal 
brush border membrane vesicles, was actually increased 
in the presence of EGTA. Although CaM contains 4 EF 
hand helix-loop-helix structures that are required for 
the binding of calcium and CaBP-Dtlk contains 2, it 
should be noted that CaBP-DzBk contains 6 EF hands. 
This could account for the observed ifferences between 
CaBP-Dgk and CaBP-D,,k in the Ca’+-dependency of 
binding to the Ca’+‘-ATPase. However. equilibrium 
dialysis studies have indicated that C&P-D,,, binds, 
only 3-4 mol of Ca”/mol protein [3] in agreement with 
the fact that 2 of the 6 potential Ca”’ loops lack some 
of the requisite ligand forming residues [39]. 
We previously reported that CaBP-Dzfik did not ac- 
tivate PDE [13]. In the present studies care was taken 
not to freeze and thaw preparations of CaBP-D,,, 
(which we have observed to result in the loss of its 
stimulatory activity). Proteolytic enzyme inhibitors also 
were used throughout he purification procedure and all 
experiments were performed only with recent prepara- 
tions of the protein. Since activation by CaBP-DzNk was 
critically dependent on the preparation of purified pro- 
tein, we conclude that variability in the techniques used 
to prepare CaBP-D,yk may indeed have accounted for 
some of the conflicting data in the past. 
The physiological relevance of the Ca’+-independent 
activities of CaBP-Dznk shown here is unclear as has also 
been noted for CaBP-D,, [12]. CaM is present at high 
concentrations inall animal tissues [2] and would clearly 
be the primary activator of these enzymes at elevated 
CO)+ concentrations. It is intriguing, however, that spc- 
cific neuronal sub-types which express relatively high 
levels of CaBP-D2,, show enhanced resistance to Ca”’ 
toxicity [7], suggesting an alteration in Ca”’ sequester- 
ing capability. It is possible that CaBP-D?!,, might re- 
present an alternative activation mechantsm for the 
Ca2+ pump which would operate at free Ca”’ conccntra- 
tions lower than required for GM-mediated activation 
to ensure maintenance of resting state Ca” levels in 
specific cell types. The fact that CaBP-Dznk is a highly 
conserved member of the calcium binding protein fam- 
ily [4,38] which appears to possess target protein bind- 
ing properties related to CaM also raises the possibility 
that it may function as a Ca”+-dependent regulator of 
target proteins yet to be identified. 
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